1. Home
  2. CRGY vs SUPN Comparison

CRGY vs SUPN Comparison

Compare CRGY & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crescent Energy Company

CRGY

Crescent Energy Company

HOLD

Current Price

$8.51

Market Cap

2.3B

Sector

Energy

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$49.23

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRGY
SUPN
Founded
1986
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.9B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
CRGY
SUPN
Price
$8.51
$49.23
Analyst Decision
Buy
Strong Buy
Analyst Count
11
5
Target Price
$14.10
$61.60
AVG Volume (30 Days)
5.5M
602.1K
Earning Date
02-25-2026
02-24-2026
Dividend Yield
5.64%
N/A
EPS Growth
N/A
N/A
EPS
0.10
N/A
Revenue
$3,590,024,000.00
$681,539,000.00
Revenue This Year
$28.94
$8.32
Revenue Next Year
$24.77
$23.36
P/E Ratio
$81.94
N/A
Revenue Growth
32.31
4.54
52 Week Low
$6.83
$29.16
52 Week High
$16.94
$57.65

Technical Indicators

Market Signals
Indicator
CRGY
SUPN
Relative Strength Index (RSI) 45.44 52.86
Support Level $8.04 $51.01
Resistance Level $8.56 $52.30
Average True Range (ATR) 0.28 1.38
MACD -0.03 0.05
Stochastic Oscillator 29.25 49.85

Price Performance

Historical Comparison
CRGY
SUPN

About CRGY Crescent Energy Company

Crescent Energy Co is an independent energy company with a portfolio of assets in key basins across the lower 48 states. The company maintains a diverse portfolio of assets in key basins across the United States, including the Eagle Ford, Rockies, Barnett, Permian, and Mid-Con. It seeks to deliver attractive risk-adjusted investment returns and predictable cash flows across cycles with a focus on operated oil and gas assets complemented by non-operated assets, mineral and royalty interests, and midstream infrastructure.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: